发明名称
摘要 <p>Topical compositions are disclosed that are useful for delivering a therapeutic level of an NSAID to a target within a subject having a local inflammatory disorder. A composition of the present invention comprises a Drug and a solvent system, wherein the solvent system comprises at least two solvent alcohols and wherein the solvent system is present in an amount sufficient to solubilize the Drug, the solvent system is a low alkanol system, and the composition is a single phase composition. Exemplary solvent systems are those for which one of the at least two solvent alcohols is polyethylene glycol, glycerin, butylene glycol, dipropylene glycol, propylene glycol, ethanol, isopropanol, or a derivative thereof. Optionally the local inflammatory disorder is pseudofolliculitis barbae, dermatitis, psoriasis, wounds, or sunburn.</p>
申请公布号 JP2010502701(A) 申请公布日期 2010.01.28
申请号 JP20090527359 申请日期 2007.08.28
申请人 发明人
分类号 A61K31/192;A61K31/167;A61K31/196;A61K31/245;A61K31/405;A61K31/407;A61K31/4152;A61K31/423;A61K31/436;A61K31/45;A61K31/455;A61K31/5415;A61K47/10;A61K47/34;A61P17/00;A61P17/02;A61P17/08;A61P17/16;A61P29/00;A61P31/00;A61P43/00 主分类号 A61K31/192
代理机构 代理人
主权项
地址